Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Annexon, inc. crawled time : 12:03 save search
Annexon Advances Classical Complement Platform with Initiation of Global Phase 2 ARCHER Trial in Patients with Geographic Atrophy
Published: 2021-03-01 (Crawled : 12:03) - globenewswire.com
ANNX | $4.6 3.6% 620K
|
Health Technology
|
| O: 3.13%
H: 7.26%
C: -0.37%
phase 2 trial
Annexon Highlights Recent Achievements and Outlines Expected Key Milestones in 2021 for Its Broad Portfolio of Complement Therapeutics
Published: 2021-01-12 (Crawled : 12:03) - globenewswire.com
ANNX | $4.6 3.6% 620K
|
Health Technology
|
| O: -0.95%
H: 5.91%
C: 2.52%
milestone
Annexon to Present at the J.P. Morgan 39th Annual Healthcare Conference
Published: 2021-01-05 (Crawled : 12:03) - globenewswire.com
ANNX | $4.6 3.6% 620K
|
Health Technology
|
| O: -0.63%
H: 0.63%
C: -4.92%
Annexon Announces Initiation of Phase 2/3 Trial of ANX005 in Patients with Guillain-Barré Syndrome
Published: 2020-12-21 (Crawled : 12:03) - globenewswire.com
ANNX | $4.6 3.6% 620K
|
Health Technology
|
| O: -2.28%
H: 0.97%
C: -7.1%
trial phase 2 phase 2/3 syndros
Gainers vs Losers
| 71% | 29% |
Top 10 Gainers
AGBA | News | $1.27 217.5% 120M
|
Finance
EGOX | $0.0503 39.72% 320M
|
RWOD | $10.52 31.56% 5.9M
|
n/a
ZCMD | $1.905 31.38% 30M
|
Commercial Services
MRDB 4 | $0.536 27.65% 2M
|
n/a
BSFC | $0.0822 27.64% 75M
|
Manufacturing
TPET | $0.4121 25.68% 45M
|
n/a
NVFY | $2.65 25.59% 33M
|
Consumer Durables
INDO | $5.1 25.0% 15M
|
Energy Minerals
CHRO | $1.53 24.9% 100K
|
n/a
Your saved searches
Save your searches and get alerts when important news are released.